EUVIMEDEUVIMED entdecken
Crossref

Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes

Travis H Smith, Jeffrey Jean, Stephen Phan, Alexandra E Kovach, Karin Miller, Jennifer Han, Katherine Ma, Cindy Fong, Andrew Doan, Deepa Bhojwani, Gordana Raca

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2025.100937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Travis H Smith und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Keck School of Medicine of University of South California, Los Angeles, California. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Chromosome Mapping, Leukemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematologic neoplasms in pediatric patients have different genomic profiles compared with the same malignancies in adults, with copy number abnormalities (CNAs) and balanced structural variants (SVs) being the most prevalent types of oncogenic drivers. Consequently, we hypothesized that optical genome mapping (OGM), as a new method for genome-wide, high-resolution detection of CNAs and balanced SVs, could represent a powerful testing approach for pediatric leukemias. This study compared the performance of OGM in the detection of clinically significant variants with current standard-of-care (SOC) diagnostic methodologies, including karyotyping, fluorescence in situ hybridization (FISH), chromosomal microarray, and a custom pediatric next-generation sequencing panel, OncoKids. In a retrospective review of results from SOC genetic testing and OGM for 100 de novo or relapsed pediatric hematologic neoplasms, full concordance was observed in 71% of cases. A clinically significant finding (tier 1 or 2 based on the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists guidelines) was missed by OGM in 7 cases, but in 22 cases, OGM identified additional tier 1 or 2 findings missed by SOC testing. The highest increase in diagnostic yield was noted in T-lymphoblastic leukemia/lymphoma (T-ALL), with nearly 40% (9/23) of T-ALL cases having additional tier 1 or 2 findings detected using OGM. The main advantage of OGM was the ability to detect cytogenetically cryptic, balanced rearrangements not targeted by routine FISH probes or OncoKids, whereas its main limitation was low resolution for identifying copy-neutral loss of heterozygosity. As a single assay, OGM detected the majority (92%) of clinically significant variants identified by the combined use of karyotyping, FISH, chromosomal microarray, and OncoKids, and revealed additional tier 1 or 2 variants missed by SOC testing in 22% of the cases. Our study shows that OGM represents a powerful assay for detection of CNAs and balanced SVs in pediatric hematologic neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsChromosome MappingLeukemiaHumansChildFemaleMaleChild, PreschoolAdolescentRetrospective StudiesInfantIn Situ Hybridization, FluorescenceDNA Copy Number VariationsKaryotypingHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

cytogeneticshematopathologyoptical genome mappingpediatric leukemia

Autor:innen und Institutionen

  • Department of Pathology, Keck School of Medicine of University of South California, Los Angeles, California.
  • Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California; Now with Departments of Laboratory Medicine and Pathology, Boston Children's Hospital, Boston, Massachusetts.
  • Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California.
  • Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California.
  • Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California.
  • Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California. Electronic address: graca@chla.usc.edu.

Zitieren

APA

Smith, T. H., Jean, J., Phan, S., Kovach, A. E., Miller, K., Han, J., Ma, K., Fong, C., Doan, A., Bhojwani, D., & Raca, G. (2026). Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100937

Vancouver

Smith TH, Jean J, Phan S, Kovach AE, Miller K, Han J, et al. Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes. Modern Pathology. 2026. doi:10.1016/j.modpat.2025.100937

BibTeX
@article{Smith2026,
  author = {Smith, Travis H and Jean, Jeffrey and Phan, Stephen and Kovach, Alexandra E and Miller, Karin and Han, Jennifer and Ma, Katherine and Fong, Cindy and Doan, Andrew and Bhojwani, Deepa and Raca, Gordana},
  title = {Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2025.100937}
}
Kostenlos starten →